| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T407 |
0-242 |
Sentence |
denotes |
In addition to therapeutic approaches using Treg cell infusion, another three clinical trials are underway with the aim of evaluating treatment using specific SARS-CoV-2 T cells isolated from individuals who recovered from COVID-19 (290–292). |
| T408 |
243-429 |
Sentence |
denotes |
The use of virus-specific T cells for off-the-shelf treatment has been used in several viral infections, such as cytomegalovirus, HHV6, adenoviruses, Ebola virus, and BK virus (293–296). |
| T409 |
430-748 |
Sentence |
denotes |
Although vaccination provides T cells-based virus-specific immunity, the path to its development is long, so the use of adoptive cell transfer techniques from healthy individuals who recovered from COVID-19 and developed an effective cell response is probably the fastest way to treat critically ill individuals (297). |
| T410 |
749-1024 |
Sentence |
denotes |
Besides that, as mentioned before, asymptomatic or mild symptomatic patients may possibly mount robust SARS-CoV-2 specific CD8+ T cell responses (200, 201), therefore, the use of these individuals’ cells to treat critically ill patients with COVID-19 can be a promising tool. |
